Celiac Disease Clinical Trial
Official title:
Understanding the Relationship Between the MicrobiOme, Vitality and Exercise in Celiac Disease (MOVE-C)
Engagement in regular physical activity (PA) is associated with a range of physical and psychological benefits among chronic disease populations. Celiac disease is a chronic autoimmune condition that requires strict adherence to a gluten-free diet (GFD) for the best medical outcomes, as well as to prevent detrimental health outcomes including bloating, diarrhea, constipation, and increased risk of intestinal cancers and osteoporosis. Despite following a GFD, individuals with celiac disease often report dissatisfaction with the diet, are less likely to engage in social activities, can have an imbalance in gut bacteria and up to 30% still report negative symptoms (e.g., gastro-intestinal upset). Furthermore, preliminary research revealed that rates of PA among those with celiac disease are dismal, with the majority of participants failing to engage in regular PA. The purpose of this pilot research project is to examine the effects of a 12-week structured exercise program on inactive adults with celiac disease. It is anticipated that compared to those in a wait-list control condition, participants who engage in the 12-week exercise program will report greater improvements in quality of life and experience improved balance of gut bacteria. The findings from this project may reveal an additional strategy to optimize health while living with celiac disease. In addition, results from this study will provide essential pilot data that will inform a grant application for a larger clinical trial to further investigate the role of exercise in the promotion of health and well-being among those with celiac disease.
Background & Rationale:
Engagement in regular physical activity (PA) is associated with a range of physical and
psychological benefits among chronic disease populations. Quality of life (QoL) is
significantly higher among people with cancer, depression and coronary heart disease who
engage in PA on a regular basis. Risk of other chronic diseases such as type 2 diabetes is
significantly reduced when people engage in regular PA. In addition, findings from a recent
intervention study revealed that after engaging in a 12-week structured exercise program,
cancer survivors had improvements in physical functioning, and reductions in fatigue and
tiredness.
One chronic disease population that could particularly benefit from engaging in regular PA is
people with celiac disease. Celiac disease is a chronic autoimmune condition and the
incidence has increased 4 to 5 times over the past 50 years. Strict adherence to a
gluten-free diet (GFD) is currently the only treatment for preventing both short- and
long-term consequences from celiac disease (e.g., infertility, intestinal cancers,
osteoporosis). Unfortunately, preliminary research revealed that rates of PA among those with
celiac disease are dismal, with the majority of participants failing to engage in regular PA.
Further, following a strict GFD alone may not be sufficient to effectively manage the
disease, and can be associated with detrimental outcomes including reduced QoL. Despite
following a GFD, individuals with celiac disease report high treatment burden, lower social
engagement, fatigue, altered gut microbiota, and up to 30% still report negative symptoms
(e.g., gastro-intestinal upset). Given the benefits of engagement in regular PA for other
chronic disease populations, helping people with celiac disease become more physically active
may lead to improvements in QoL and physiological outcomes.
High-Intensity Interval Training (HIIT) has been found to be appropriate for those with
lifestyle-induced chronic diseases, including type 2 diabetes, atherosclerotic cardiovascular
disease and metabolic syndrome. HIIT involves repeated bouts of high intensity effort
followed by varied recovery times and can be easily modified for people of all fitness levels
and chronic conditions. For example, Jung and colleagues reported on the benefits of HIIT for
people with pre-diabetes and found that compared to participants engaging in moderate
intensity continuous training, participants who engaged in regular bouts of HIIT exercise had
better adherence to independent exercise. Martinez et al. found that participants who engaged
in shorter interval training (e.g., HIIT), reported more pleasure and enjoyment of the
exercise when compared to heavy, continuous or longer interval exercise. In addition to
improvements in behavioural outcomes, Denou and colleagues recently found that HIIT also led
to improvements in the gut microbiota of mice with diet induced obesity. Given that people
with celiac disease are at increased risk of metabolic syndrome and are likely to have gut
dysbiosis (imbalance in gut microorganisms), it is anticipated that HIIT may lead to
improvements in key psychosocial (e.g., QoL) and behavioural outcomes (i.e., exercise
adherence). Further, key markers of metabolic syndrome and balance in the gut microbiota may
be positively impacted.
Study aims:
The proposed study is an innovative examination of the effects of exercise on physiological
and patient-reported outcomes among people with celiac disease. Specifically, we will explore
the effects of a 12-week HIIT and lifestyle intervention on QoL, gut microbiota profile,
independent PA, fatigue, and markers of metabolic syndrome (waist circumference, fasting
glucose, serum lipids, blood pressure) among people with celiac disease who are currently
sedentary (i.e., not meeting Canada's PA Recommendations (150 minutes of weekly activity at a
moderate intensity or greater).
Exercise program:
The 12-week exercise program will entail two 60-minute structured group exercise sessions per
week. As participants will not be meeting the recommended guidelines for weekly PA, workouts
will be progressive in nature and an initial conditioning phase will be integrated into the
12-week program. Participants will begin with 20-30 minute exercise sessions and progress to
40-60 minute sessions over the course of 12 weeks. Each class will consist of warm-up,
training period, cool-down and flexibility sections. Participants will have the option of
using various pieces of equipment, including stationary bikes, treadmills and ellipticals.
All participants will wear heart rate monitors in order to monitor workout intensity.
Participants' programs will be designed by a Canadian Society of Exercise Physiology (CSEP)
Certified Exercise Physiologist® and exercise classes will be supervised by a CSEP-Certified
Personal Trainer®.
Education sessions:
Participants in the exercise condition will participate in 30-minute bi-weekly group
education sessions. Education will pertain to learning about the importance of following a
nutritious, whole foods-based GFD to effectively manage celiac disease, communication
strategies, effective sleep hygiene practices, and strategies to overcome barriers to
following a strict GFD. Participants will also be taught behaviour change skills based on the
theoretically-based group-mediated cognitive behavioural (GMCB) approach. GMCB interventions
teach participants how to self-monitor daily activity, set goals and overcome barriers to
regular PA. To prevent dependence on the group, self-regulation becomes a greater emphasis
over the course of the GMCB sessions. Previous GMCB interventions have lead to greater
improvements in frequency of PA, long-term adherence, fitness, self-efficacy for mobility,
and barrier self-efficacy.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04349904 -
Near-Focus NBI Classification of Villous Atrophy in Suspected Coeliac Disease: International Development and Validation
|
||
Recruiting |
NCT05581628 -
FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
|
||
Completed |
NCT04593251 -
Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis
|
Phase 1 | |
Completed |
NCT05810441 -
Intestinal Transglutaminase Antibodies in Celiac Disease Diagnosis
|
||
Recruiting |
NCT05555446 -
Bovine Colostrum to Prevent Absorption of Gluten
|
Early Phase 1 | |
Completed |
NCT02754609 -
Hookworm Therapy for Coeliac Disease
|
Phase 1 | |
Terminated |
NCT01902368 -
Celiac Disease Screening
|
N/A | |
Completed |
NCT02472704 -
Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo
|
N/A | |
Completed |
NCT02312349 -
Assessment of Gluten-Free Availability in Elaborated Food Stores in Three Neighbourhoods of Buenos Aires City
|
||
Completed |
NCT01172665 -
Celiac Disease Database
|
||
Completed |
NCT01100099 -
HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease
|
Phase 2/Phase 3 | |
Completed |
NCT00639444 -
Risk of Celiac Disease and Age at Gluten Introduction
|
N/A | |
Active, not recruiting |
NCT05425446 -
Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients
|
Phase 1 | |
Enrolling by invitation |
NCT02202681 -
Imaging the Duodenum Using an Optical Frequency Domain Imaging OFDI Capsule
|
N/A | |
Completed |
NCT00362856 -
Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects
|
Phase 2 | |
Terminated |
NCT03866538 -
Budesonide in Patients With Immune Mediated Enteropathies
|
Phase 4 | |
Recruiting |
NCT05135923 -
Glutenfree, Gut Microbiota and Metabolic Regulation
|
N/A | |
Completed |
NCT05052164 -
Improvement Of Physical And Physiological Parameters In Menopausal Or Post-Menopausal Celiac Women
|
N/A | |
Completed |
NCT03775499 -
Probiotic BL NCC 2705 and Gluten Sensitivity
|
N/A | |
Completed |
NCT03707730 -
A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease
|
Phase 2 |